Literature DB >> 25381017

Overexpression of NRG1 promotes progression of gastric cancer by regulating the self-renewal of cancer stem cells.

Myoung-Eun Han1, Hyun-Jung Kim, Dong Hoon Shin, Sun-Hwi Hwang, Chi-Dug Kang, Sae-Ock Oh.   

Abstract

BACKGROUND: Gastric cancer stem cells (GCSCs) have been successfully isolated from patients. However, the molecular mechanisms underlying the self-renewal of GCSCs and their relationship with the microenvironment are poorly characterized.
METHODS: GCSCs and cancer-associated fibroblasts (CAFs) were cultured directly from gastric cancer patients. The self-renewal of GCSCs was assayed by sphere formation assay and in vivo tumorigenicity. Expression of neuregulin1 (NRG1) was examined by immunohistochemistry, real-time PCR and western blotting.
RESULTS: CAFs increased the self-renewal of GCSCs by secreting NRG1. NRG1 activated NF-κB signaling and this activation regulated GCSC self-renewal. Moreover, NF-κB-active GCSCs were tumorigenic, however NF-κB-inactive GCSCs were not. The overexpression of NRG1 in stromal cells and cancer cells was observed in the tumor tissues of gastric cancer patients and was associated with clinical stage lymph node metastasis and survival in gastric cancer patients. In addition, we also found that NRG1 can regulate the proliferation and invasion of gastric cancer cells.
CONCLUSIONS: These results indicate that NRG1, which can be secreted by CAFs or cancer cells, promotes progression of gastric cancer by regulating the self-renewal of GCSCs and its overexpression is associated with a prognosis of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25381017     DOI: 10.1007/s00535-014-1008-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  33 in total

Review 1.  Dysregulation of cellular signaling in gastric cancer.

Authors:  William K K Wu; Chi H Cho; Chung W Lee; Daiming Fan; Kaichun Wu; Jun Yu; Joseph J Y Sung
Journal:  Cancer Lett       Date:  2010-05-21       Impact factor: 8.679

2.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling.

Authors:  Astrid De Boeck; Patrick Pauwels; Karen Hensen; Jean-Luc Rummens; Wendy Westbroek; An Hendrix; Dawn Maynard; Hannelore Denys; Kathleen Lambein; Geert Braems; Christian Gespach; Marc Bracke; Olivier De Wever
Journal:  Gut       Date:  2012-04-25       Impact factor: 23.059

4.  Clinical significance of intratumoral HER2 heterogeneity in gastric cancer.

Authors:  Hee Eun Lee; Kyoung Un Park; Seol Bong Yoo; Soo Kyung Nam; Do Joong Park; Hyung-Ho Kim; Hye Seung Lee
Journal:  Eur J Cancer       Date:  2012-11-09       Impact factor: 9.162

5.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

Authors:  Catherine A O'Brien; Aaron Pollett; Steven Gallinger; John E Dick
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

6.  ErbB receptor tyrosine kinase/NF-κB signaling controls mammosphere formation in human breast cancer.

Authors:  Kunihiko Hinohara; Seiichiro Kobayashi; Hajime Kanauchi; Seiichiro Shimizu; Kotoe Nishioka; Ei-ichi Tsuji; Kei-ichiro Tada; Kazuo Umezawa; Masaki Mori; Toshihisa Ogawa; Jun-ichiro Inoue; Arinobu Tojo; Noriko Gotoh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-05       Impact factor: 11.205

Review 7.  Roles for neuregulins in human cancer.

Authors:  Christophe Stove; Marc Bracke
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

8.  Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies.

Authors:  Murielle Mimeault; Sonny L Johansson; Surinder K Batra
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

Review 9.  Hypoxia inducible factors in cancer stem cells.

Authors:  J M Heddleston; Z Li; J D Lathia; S Bao; A B Hjelmeland; J N Rich
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

10.  Gastric stem cells and gastric cancer stem cells.

Authors:  Myoung-Eun Han; Sae-Ock Oh
Journal:  Anat Cell Biol       Date:  2013-03-25
View more
  17 in total

1.  Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G).

Authors:  Yuji Miura; Yasutaka Sukawa; Shuichi Hironaka; Misuzu Mori; Kazuhiro Nishikawa; Shinya Tokunaga; Hiroyuki Okuda; Takeshi Sakamoto; Keisei Taku; Kazuo Nishikawa; Toshikazu Moriwaki; Yuji Negoro; Yutaka Kimura; Keita Uchino; Katsunori Shinozaki; Hiroharu Shinozaki; Nobuyuki Musha; Hirotsugu Yoshiyama; Takashi Tsuda; Yoshinori Miyata; Naotoshi Sugimoto; Tsuyoshi Shirakawa; Miki Ito; Kimio Yonesaka; Kenichi Yoshimura; Narikazu Boku; Katsuhiko Nosho; Toshimi Takano; Ichinosuke Hyodo
Journal:  Gastric Cancer       Date:  2017-05-11       Impact factor: 7.370

2.  Cancer-associated fibroblasts regulate the biological behavior of cancer cells and stroma in gastric cancer.

Authors:  Qian Zhang; Chunwei Peng
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

3.  Psoralidin inhibits proliferation and enhances apoptosis of human esophageal carcinoma cells via NF-κB and PI3K/Akt signaling pathways.

Authors:  Zhiliang Jin; Wei Yan; Hui Jin; Changzheng Ge; Yanhua Xu
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

4.  α1,6-Fucosyltransferase (FUT8) regulates the cancer-promoting capacity of cancer-associated fibroblasts (CAFs) by modifying EGFR core fucosylation (CF) in non-small cell lung cancer (NSCLC).

Authors:  Fengzhou Li; Shilei Zhao; Yanwei Cui; Tao Guo; Jiaqi Qiang; Qiang Xie; Wendan Yu; Wei Guo; Wuguo Deng; Chundong Gu; Taihua Wu
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

5.  HER4 isoform CYT2 and its ligand NRG1III are expressed at high levels in human colorectal cancer.

Authors:  Yan Guo; Zhihui Duan; Yitao Jia; Chaoying Ren; Jian Lv; Peng Guo; Wujie Zhao; Bin Wang; Suqiao Zhang; Yaxing Li; Zhongxin Li
Journal:  Oncol Lett       Date:  2018-02-27       Impact factor: 2.967

6.  Integrated genomic profiling expands clinical options for patients with cancer.

Authors:  Nike Beaubier; Martin Bontrager; Robert Huether; Catherine Igartua; Denise Lau; Robert Tell; Alexandria M Bobe; Stephen Bush; Alan L Chang; Derick C Hoskinson; Aly A Khan; Emily Kudalkar; Benjamin D Leibowitz; Ariane Lozachmeur; Jackson Michuda; Jerod Parsons; Jason F Perera; Ameen Salahudeen; Kaanan P Shah; Timothy Taxter; Wei Zhu; Kevin P White
Journal:  Nat Biotechnol       Date:  2019-09-30       Impact factor: 68.164

7.  Regulation of inflammatory responses by neuregulin-1 in brain ischemia and microglial cells in vitro involves the NF-kappa B pathway.

Authors:  Lauren J Simmons; Monique C Surles-Zeigler; Yonggang Li; Gregory D Ford; Gale D Newman; Byron D Ford
Journal:  J Neuroinflammation       Date:  2016-09-06       Impact factor: 8.322

Review 8.  Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms.

Authors:  Toshimitsu Yamaoka; Motoi Ohba; Tohru Ohmori
Journal:  Int J Mol Sci       Date:  2017-11-15       Impact factor: 5.923

Review 9.  NF-κB Signaling in Gastric Cancer.

Authors:  Olga Sokolova; Michael Naumann
Journal:  Toxins (Basel)       Date:  2017-03-28       Impact factor: 4.546

Review 10.  Drug Resistance Driven by Cancer Stem Cells and Their Niche.

Authors:  Marta Prieto-Vila; Ryou-U Takahashi; Wataru Usuba; Isaku Kohama; Takahiro Ochiya
Journal:  Int J Mol Sci       Date:  2017-12-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.